Lung cancer
Conditions
Interventions
treatment group:YiQi YangYin prescription+Chemotherapy + Angiogenesis inhibitor ± PD-1 inhibitor
Control group:Chemotherapy + Angiogenesis inhibitor ± PD-1 inhibitor
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age =18 years old and =75 years old gender is not limited; (2) Patients with pathologically or cytologically confirmed non-small cell lung cancer; (3) TNM stage III-IV with evaluable target lesions; (4) Chemotherapy combined with bevacizumab combined or non-combined immunotherapy should be used for second-line and above; (5) TCM syndrome type is Qi-Yin deficiency type patients; (6) PS (physical condition score) score < 3 expected survival =3 months.
Exclusion criteria
Exclusion criteria: (1) Serious uncontrolled organic disease or infection; (2) Active bleeding or arterial thromboembolism or gastrointestinal perforation; (3) Urinary protein greater than 2g/24h or abnormal blood routine liver and kidney function more than 3 degrees or stool occult blood more than 3+; (4) Patients who have received major surgery within one month; (5) Patients unable to eat; (6) Those who are unable to fill in the scale due to the disorder of consciousness and literacy; (7) Patients with a history of uncontrollable mental illness; (8) People who are allergic to Chinese medicine ingredients in this study; (9) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective Response Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| ;Disease Control Rate;Progression-Free-Survival;Hematological Testing; | — |
Countries
China
Contacts
Public ContactXuanting Ye
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Outcome results
None listed